AstraZeneca started latestage trials on Saturday of an experimental longacting monoclonal antibody combination drug it hopes could be used as a socalled prophylactic to prevent COVID19 infection in atrisk people for up to 12 months.from Top World News- News18.com https://ift.tt/2UIMELk
No comments:
Post a Comment